Verrica Pharmaceuticals Inc. Share Price

Verrica Pharmaceuticals Inc. Share Price

NASDAQ: VRCA | Micro Cap
$3.13
-$0.18 (-5.44%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Verrica Pharmaceuticals Inc. Stock Performance

Open
$3.42
Prev. Close
$3.31
Circuit Range
N/A
Day Range
$2.77 - $3.42
Year Range
$2.77 - $9.58
Volume
4,644
Average Traded
$3.10

Verrica Pharmaceuticals Inc. Share Price Today

As of 18 November 2026, Verrica Pharmaceuticals Inc.'s share price is $3.13. The stock opened at $3.42, compared to its previous close of $3.31. During today's trading session, Verrica Pharmaceuticals Inc.'s share price traded between $2.77 and $3.42, with an average price of $3.10. Over the past 52 weeks, the stock has recorded a high of $9.58 and a low of $2.77. In terms of performance, Verrica Pharmaceuticals Inc.'s share price has declined by 46.95% over the last six months and is down 65.49% on a year-on-year basis.

Verrica Pharmaceuticals Inc. Share Price Chart

Line chart of the Verrica Pharmaceuticals Inc. price trend over the selected period. The price fell overall, ranging from 2.77 to 3.40, ending at 3.13.
$2.77$3.42
L
Show Current Price
H

Verrica Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Market Cap
$33.34M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.82
Revenue (TTM)
$35.58B
Return On Equity (TTM)
-724.01%
Profit Margin
-50.28%
Debt to Equity
0.32
Quarterly Earnings Growth YoY
-4770.37%

Verrica Pharmaceuticals Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$14.34$5.09$5.02$5.86
Net Profit-$0.27-$8.07-$9.68-$13.15
Net Profit Margin-1.88%-158.55%-192.83%-224.40%
Income ChangeN/A-2888.89%-19.95%-35.85%

Verrica Pharmaceuticals Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$9.03$5.12$7.57$35.58
Net Profit-$24.49-$67.00-$76.58-$17.89
Net Profit Margin-271.21%-1308.59%-1011.62%-50.28%
Income ChangeN/A-173.58%-14.30%76.64%

About Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Verrica Pharmaceuticals Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.31
$3.03
-10.88%
Oct 2026
$4.65
$3.40
-25.27%
Sep 2026
$5.42
$4.55
-9.00%
Aug 2026
$5.42
$5.00
-6.02%
Jul 2026
$6.17
$5.32
-13.50%
Jun 2026
$5.90
$6.15
+4.24%
May 2026
$6.31
$5.90
-8.53%
Apr 2026
$5.55
$6.45
+23.09%
Mar 2026
$5.41
$5.24
-4.20%
Feb 2026
$7.55
$5.47
-22.41%
Jan 2026
$8.30
$7.05
-15.16%
Dec 2025
$7.99
$8.31
-8.38%

VRCA Share Price FAQs